HLB Life Science

HLB생명과학 · 067630

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$278.7M (₩384.6B)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$33.2M

▼ −55.2% YoY

Operating profit · FY2025

−US$16M

Loss narrowed

Net income · FY2025

−US$72.4M

Turned to loss

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$71M(₩98B)	US$74.1M(₩102.2B)	US$33.2M(₩45.8B)
Operating profit	−US$17.8M(−₩24.5B)	−US$18M(−₩24.8B)	−US$16M(−₩22B)
Net income	−US$4.3M(−₩5.9B)	US$4.5M(₩6.2B)	−US$72.4M(−₩99.9B)

Revenue

Operating profit

Net income

ROE

-33.6%

Debt/Eq

60.6%

Op. margin

-48.1%

Net margin

-218.4%

Rev. YoY

▼ −55.2%

Interactive price history isn't here yet. Would you use it?